Last reviewed · How we verify

NCT03065322

The Impact of Obstructive Sleep Apnoea in Women With Polycystic Ovary Syndrome.

Completed Last updated 18 June 2024
What this trial tests

trial testing To assess risk of OSA in Polycystic Ovary Syndrome in 38 participants. Completed in 1 January 2019.

Timeline
13 February 2017
Primary endpoint
11 May 2018
1 January 2019

Quick facts

Lead sponsorUniversity Hospitals Coventry and Warwickshire NHS Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment38
Start date13 February 2017
Primary completion11 May 2018
Estimated completion1 January 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University Hospitals Coventry and Warwickshire NHS Trust

Who can join

18 and older, female only, with Polycystic Ovary Syndrome or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Women with PCOS and OSA, compared to women with PCOS only, have more severe clinical and biochemical features of PCOS and impaired QoL. This is an observational cross-sectional study in a secondary care PCOS clinic in the WISDEM Centre, University Hospital Coventry. The primary aim of this study is to examine the relationship between OSA and impaired QoL in women with PCOS. Study secondary outcomes are to examine the relationship between OSA and the clinical and biochemical features in women with PCOS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The relationship between obstructive sleep apnoea and quality of life in women with polycystic ovary syndrome: a cross-sectional study.
    Kahal H, Tahrani AA, Kyrou I, Dimitriadis GK, et al · · 2020 · cited 11× · PMID 32128106 · DOI 10.1177/2042018820906689

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other University Hospitals Coventry and Warwickshire NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03065322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing